Elda De Vita
Biographic Data
| ID | 7011915 |
|---|---|
| NAME | Elda De Vita |
| GIVEN NAMES | Elda |
| FAMILY NAME | De Vita |
| SIGNATURE | DE VITA E |
| AFFILIATIONS | University of Bari Aldo Moro |
| ORCID | 0000-0001-7403-6389 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Role of Frailty Index-Laboratory to predict Covid-19 mortality
Introduction The COVID-19 pandemic has disproportionately impacted frail individuals, highlighting the urgent need for effective prognostic tools to improve patient outcomes. Early identification of at-risk individuals can optimize management and resource allocation, reducing mortality and morbidity. This study evaluates the Frailty Index-Laboratory (FI-LAB) as a predictor of mortality in COVID-19 patients. Methods We included all COVID-19 patien…
Stool Xpert MTB/RIF as a possible diagnostic alternative to sputum in Africa
Subacute Cardiac Tamponade Due to Tuberculous Pericarditis Diagnosed by Urine Lipoarabinomannan Assay in a Immunocompetent Patient in Oyam District, Uganda
Our case highlights the potential usefulness of a LF-LAM-based diagnostic approach, suggesting that, in low-resource settings, this test might be used as part of routine diagnostic workup in patients with pericardial disease or suspected extra-pulmonary tuberculosis
No prominent works on this page.
Subacute Cardiac Tamponade Due to Tuberculous Pericarditis Diagnosed by Urine Lipoarabinomannan Assay in a Immunocompetent Patient in Oyam District, Uganda
Our case highlights the potential usefulness of a LF-LAM-based diagnostic approach, suggesting that, in low-resource settings, this test might be used as part of routine diagnostic workup in patients with pericardial disease or suspected extra-pulmonary tuberculosis
Stool Xpert MTB/RIF as a possible diagnostic alternative to sputum in Africa
Role of Frailty Index-Laboratory to predict Covid-19 mortality
Introduction The COVID-19 pandemic has disproportionately impacted frail individuals, highlighting the urgent need for effective prognostic tools to improve patient outcomes. Early identification of at-risk individuals can optimize management and resource allocation, reducing mortality and morbidity. This study evaluates the Frailty Index-Laboratory (FI-LAB) as a predictor of mortality in COVID-19 patients. Methods We included all COVID-19 patien…
Internal Medicine (2 works) · Medicine (2 works) · Asymptomatic (1 works) · Cardiac tamponade (1 works) · Chest pain (1 works) · Confidence interval (1 works) · Demographics (1 works) · Demography (1 works) · Disease (1 works) · Emergency Medicine (1 works)